đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
CLAG-M is an active, well tolerated regimen in acute myelogenous leukemia. ...
Status
Unknown
Location
Westchester Medical Center/New York Medical College
Start Date
2012-01
Trial ID
NCT01513603
The goal of this clinical trial is to show that incorporating ofatumumab in...
Status
Completed
Location
University of California, San Francisco
Start Date
2012-05-25
Trial ID
NCT01555541
Treatments Being Tested
The study will include newly-diagnosed AML patients, not suffering acute pr...
Status
Unknown
Location
Weill Cornell Medicine
Start Date
2017-07-03
Trial ID
NCT03257241
Treatments Being Tested
This Phase 1/2 study will evaluate the safety, efficacy, PK, and PD of FT-2...
Status
Completed
Location
UCLA Medical Center
Start Date
2016-04-30
Trial ID
NCT02719574
Treatments Being Tested
The purpose of this study is to investigate the clinical efficacy of high-d...
Status
Unknown
Location
Department of Hematology, Nagoya University Graduate School of Medicine
Start Date
2002-09
Trial ID
NCT00131027
QUESTIONS AND OBJECTIVES OF ALL-MB-2008 STUDY 1. Whether the early PEG-asp...
Status
Unknown
Location
Republican Research and Practical Center of Radiation Medicine
Start Date
2008-02
Trial ID
NCT01953770
This phase II trial tests how well venetoclax with cladribine and cytarabin...
Status
Recruiting
Location
University of Miami Miller School of Medicine-Sylvester Cancer Center
Start Date
2025-01-03
Trial ID
NCT06504459
Phase I trial to study the effectiveness of augmerosen plus fludarabine and...
Status
Completed
Location
Arthur G. James Cancer Hospital - Ohio State University
Start Date
1999-10
Trial ID
NCT00004862
Treatments Being Tested
An open-label, single-arm, multicenter, prospective clinical study of Hanli...
Status
Recruiting
Location
Department of Oncology, The First Affiliated Hospital of Zhengzhou University
Start Date
2022-08-12
Trial ID
NCT05506410
Treatments Being Tested
RATIONALE: Interferon alfa may interfere with the growth of cancer cells. D...
Status
Completed
Location
Hackensack University Medical Center
Start Date
1997-11-20
Trial ID
NCT00002868